SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Godavari Drugs - Quaterly Results

12 Feb 2025 Evaluate
The Sales for the quarter ended December 2024 of Rs. 295.52 million declined by -31.45% from Rs. 431.10 millions.A big decline of -37.23% was reported for the quarter ended December 2024 to Rs. 7.67  millions from Rs. 12.22 millions of corresponding previous quarter.A decline of 26.75 millions was observed in the OP in the quarter ended December 2024 from 35.70 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 295.52 431.10 -31.45 878.48 1180.71 -25.60 1567.12 1596.25 -1.82
Other Income 0.98 0.50 96.00 8.72 5.05 72.67 6.18 6.55 -5.65
PBIDT 26.75 35.70 -25.07 95.87 93.37 2.68 139.22 105.76 31.64
Interest 11.10 12.75 -12.94 36.25 36.83 -1.57 49.15 39.27 25.16
PBDT 15.65 22.37 -30.04 59.62 55.96 6.54 89.17 68.79 29.63
Depreciation 6.44 4.95 30.10 17.76 14.63 21.39 19.95 19.44 2.62
PBT 9.21 17.42 -47.13 41.86 41.33 1.28 69.22 49.35 40.26
TAX 1.54 5.20 -70.38 6.99 12.46 -43.90 13.73 11.49 19.50
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 7.67 12.22 -37.23 34.87 28.87 20.78 55.49 37.86 46.57
Equity 75.30 75.30 0.00 75.30 75.30 0.00 75.31 75.31 0.00
PBIDTM(%) 9.05 8.28 9.31 10.91 7.91 38.00 8.88 6.63 34.08

Godavari Drugs Share Price

124.95 -0.85 (-0.68%)
05-May-2026 13:44 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1815.30
Dr. Reddys Lab 1271.50
Cipla 1326.65
Zydus Lifesciences 910.55
Lupin 2345.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×